ID: ALA4080867

Max Phase: Preclinical

Molecular Formula: C26H46N4O

Molecular Weight: 430.68

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCCCCCc1nc(N2CCC2)nc(N2CCC2)c1O

Standard InChI:  InChI=1S/C26H46N4O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18-23-24(31)25(29-19-16-20-29)28-26(27-23)30-21-17-22-30/h31H,2-22H2,1H3

Standard InChI Key:  UDBKQKWHAZVWCX-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 430.68Molecular Weight (Monoisotopic): 430.3672AlogP: 6.63#Rotatable Bonds: 17
Polar Surface Area: 52.49Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.64CX Basic pKa: 7.45CX LogP: 8.07CX LogD: 7.75
Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.28Np Likeness Score: -0.45

References

1. Chevalier A, Khdour OM, Schmierer M, Bandyopadhyay I, Hecht SM..  (2017)  Influence of substituent heteroatoms on the cytoprotective properties of pyrimidinol antioxidants.,  25  (5): [PMID:28189395] [10.1016/j.bmc.2017.01.030]

Source